Found 9 matching trials
Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects
PHASE1The aim of this study is to investigate next-day residual effects of tasime...
Location
Vanda Investigational Site
Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)
PHASE4Hetlioz™ (tasimelteon) is used in the treatment of Non-24-Hour-Sleep-Wake D...
Location
Multiple Locations
Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder
PHASE3The purpose of this study is to evaluate the efficacy and safety of a six m...
Location
Pulmonary Associates, PA
Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
PHASE3The purpose of this study is to evaluate the safety of tasimelteon in male ...
Location
Pulmonary Associates, PA
Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
PHASE3The purpose of this study is to evaluate the maintenance effect and safety ...
Location
Pulmonary Associates, PA
Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment
PHASE1The purpose of this research study is to understand whether there is any di...
Location
Orlando Clinical Research Center
VEC-162 Study in Adult Patients With Primary Insomnia
PHASE3The purpose of this study is to evaluate the efficacy and safety of a 5 wee...
Location
Vanda Investigational Site
Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception
PHASE3The purpose of this study is to evaluate the safety of a one year open-labe...
Location
Multiple Locations
The Effects of Tasimelteon in Participants With REM Behavior Disorder (RBD)
EARLY_PHASE1To assess the effects of a daily single oral dose of 20 mg tasimelteon comp...
Location
Brigham and Women's Hospital